In contrast to that, upregulated MYBL2 was correlated with cetuximab resistance in NSCLC cells, which was mediated by Src-family kinase Yes- and Lin-promoted EGFR nuclear translocation and the binding of nuclear EGFR complexes to the MYBL2 promoter[118]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.